Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004134 (
ataxia
)
15,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Since the first mutations of the neuronal sodium channel SCN1A were identified 5 years ago, more than 150 mutations have been described in patients with epilepsy. Many are sporadic mutations and cause loss of function, which demonstrates haploinsufficiency of SCN1A. Mutations resulting in persistent sodium current are also common. Coding variants of SCN2A, SCN8A, and
SCN9A
have also been identified in patients with seizures,
ataxia
, and sensitivity to pain, respectively. The rapid pace of discoveries suggests that sodium channel mutations are significant factors in the etiology of neurological disease and may contribute to psychiatric disorders as well.
...
PMID:Sodium channel mutations in epilepsy and other neurological disorders. 1607 41
Episodic
Ataxias
(EAs) are a small group (EA1-EA8) of complex neurological conditions that manifest as incidents of poor balance and coordination. Diagnostic testing cannot always find causative variants for the phenotype, however, and this along with the recently proposed EA type 9 (EA9), suggest that more EA genes are yet to be discovered. We previously identified disease-causing mutations in the
CACNA1A
gene in 48% (
n
= 15) of 31 patients with a suspected clinical diagnosis of EA2, and referred to our laboratory for
CACNA1A
gene testing, leaving 52% of these cases (
n
= 16) with no molecular diagnosis. In this study, whole exome sequencing (WES) was performed on 16 patients who tested negative for
CACNA1A
mutations. Tiered analysis of WES data was performed to first explore (Tier-1) the
ataxia
and
ataxia
-associated genes (
n
= 170) available in the literature and databases for comprehensive EA molecular genetic testing; we then investigated 353 ion channel genes (Tier-2). Known and potential causal variants were identified in
n
= 8/16 (50%) patients in 8 genes (
SCN2A
, p.Val1325Phe;
ATP1A3
, p.Arg756His;
PEX7
, p.Tyr40Ter; and
KCNA1
, p.Arg167Met;
CLCN1
, p.Gly945ArgfsX39;
CACNA1E
, p.Ile614Val;
SCN1B
, p.Cys121Trp; and
SCN9A
,
p.Tyr1217Ter). These results suggest that mutations in these genes might cause an
ataxia
phenotype or that combinations of more than one mutation contribute to
ataxia
disorders.
...
PMID:Comprehensive Exonic Sequencing of Known Ataxia Genes in Episodic Ataxia. 3246 54